Human Genome Epidemiology Literature Finder
Records 1 - 18 (of 18 Records) |
Query Trace: Carcinoma and EZH2[original query] |
---|
Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma. PloS one 2013 8 (9): e74870. Yu Yung-Luen, Su Kuo-Jung, Hsieh Yi-Hsien, Lee Hsiang-Lin, Chen Tzy-Yen, Hsiao Pei-Ching, Yang Shun- |
Role of EZH2 polymorphisms in esophageal squamous cell carcinoma risk in Han Chinese population. International journal of molecular sciences 2014 15 (7): 12688-97. Ma Zhen-Bin, Guo Guang-Hong, Niu Qiong, Shi Ni |
Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic features. PloS one 2014 9 (4): e93635. Yu Yung-Luen, Su Kuo-Jung, Hsieh Ming-Ju, Wang Shian-Shiang, Wang Po-Hui, Weng Wei-Chun, Yang Shun- |
Effects of EZH2 promoter polymorphisms and methylation status on oral squamous cell carcinoma susceptibility and pathology. American journal of cancer research 2015 5 (11): 3475-84. Su Kuo-Jung, Lin Chiao-Wen, Chen Mu-Kuan, Yang Shun-Fa, Yu Yung-Lu |
Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System. Clinical genitourinary cancer 2017 10 16 (2): e373-e382. Gupta Sumati, Albertson Daniel, Gaston David, Heilbrun Marta E, Agarwal Neeraj, Boucher Ken, Parnell Timothy J, Liu Ting, Morgans Alicia, Madison Russell, Gowen Kyle, Miller Vincent A, Ross Jeffrey S, Ali Siraj M, Millis Sherri |
Increased EZH2 expression during the adenoma-carcinoma sequence in colorectal cancer. Oncology letters 2018 9 16 (4): 5275-5281. Ohuchi Mayuko, Sakamoto Yasuo, Tokunaga Ryuma, Kiyozumi Yuki, Nakamura Kenichi, Izumi Daisuke, Kosumi Keisuke, Harada Kazuto, Kurashige Junji, Iwatsuki Masaaki, Baba Yoshifumi, Miyamoto Yuji, Yoshida Naoya, Shono Takashi, Naoe Hideaki, Sasaki Yutaka, Baba Hid |
Association between EZH2 Genetic Variants and Hepatocellular Carcinoma in a Chinese Han Population. Clinical laboratory 2018 Jan 64 (1): 85-91. Li Siyao, Sun Shilong, Yu Shilong, Dong Zhuo, Jiang Kuo, Xiang Linlin, Li Haiyi |
EZH2 Expression is increased in BAP1-mutant renal clear cell carcinoma and is related to poor prognosis. Journal of Cancer 2018 11 9 (20): 3787-3796. Sun Chenmin, Zhao Chunchun, Li Shugen, Wang Jianqing, Zhou Qidong, Sun Jianliang, Ding Qiang, Liu Min, Ding Guanxio |
Somatic variants of potential clinical significance in the tumors of BRCA phenocopies. Hereditary cancer in clinical practice 2019 7 17 21. Buckingham Lela, Mitchell Rachel, Maienschein-Cline Mark, Green Stefan, Hu Vincent Hong, Cobleigh Melody, Rotmensch Jacob, Burgess Kelly, Usha Lyd |
Genetic alteration of histone lysine methyltransferases and their significance in renal cell carcinoma. PeerJ 2019 7 e6396. Yan Libin, Zhang Yangjun, Ding Beichen, Zhou Hui, Yao Weimin, Xu H |
The histone demethylase UTX/KDM6A in cancer: Progress and puzzles. International journal of cancer 2019 1 145 (3): 614-620. Schulz Wolfgang A, Lang Alexander, Koch Julian, Greife Annemar |
Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis. BioMed research international 2020 2020 2380124. Fan Kui, Zhang Chuan-Long, Qi Yuan-Fu, Dai Xin, Birling Yoann, Tan Zhao-Feng, Cao Fa |
Expression of the epigenetic H3K27me3 modifier genes KDM6A and EZH2 in patients with upper tract urothelial carcinoma. Oncology letters 2020 10 20 (6): 349. Wang Yue, Zhang Jin-Xia, Wang Shu-Fang, Zhang Yu, He Hui-Yi |
Predicting the prognosis of hepatocellular carcinoma based on the interaction between pyroptosis, apoptosis, and necroptosis. Clinical and experimental medicine 2022 Oct . Qian Fang, Kong Wei, Wang Shuaiqun, Wei K |
An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas. Cancer biomarkers : section A of Disease markers 2022 10 36 (1): 31-52. Gupta Amit Kumar, Kumar Man |
Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population. OncoTargets and therapy 2023 7 16 499-513. Min Gao, Yongwen Li, Hua Huang, Yaguang Fan, Ruifeng Shi, Lianchun Su, Chen Chen, Xuanguang Li, Guangsheng Zhu, Di Wu, Peijun Cao, Hongyu Liu, Jun Chen, Shirong Ka |
Tazemetostat for Tumors Harboring SMARCB1/SMARCA4 or EZH2 Alterations: Results from NCI-COG Pediatric MATCH APEC1621C. Journal of the National Cancer Institute 2023 5 . Susan N Chi, Joanna S Yi, P Mickey Williams, Sinchita Roy-Chowdhuri, David R Patton, Brent D Coffey, Joel M Reid, Jin Piao, Lauren Saguilig, Todd A Alonzo, Stacey L Berg, Nilsa C Ramirez, Alok Jaju, Joyce C Mhlanga, Elizabeth Fox, Douglas S Hawkins, Margaret M Mooney, Naoko Takebe, James V Tricoli, Katherine A Janeway, Nita L Seibel, D Williams Parso |
Genomic profiling reveals the variant landscape of sporadic parathyroid adenomas in Chinese population. The Journal of clinical endocrinology and metabolism 2023 1 . Tao Xiaohui, Xu Tian, Lin Xiaoyun, Xu Shuqin, Fan Youben, Guo Bomin, Deng Xianzhao, Jiao Qiong, Chen Lihui, Wei Zhe, Chen Chengkun, Yang Wendi, Zhang Zhenlin, Yu Xiangtian, Yue H |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: